Socioeconomic Costs of Chronic Kidney Disease: Evidence from Southwest Vietnam
Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 6
Abstract
ABSTRACT Introduction: Chronic Kidney Disease (CKD) has a high mortality in developing countries. This burden is increasing rapidly in Vietnam. The high cost of medication and haemodialysis are major barriers in the successful treatment of CKD. Aim: To determine from a societal perspective the complete cost associated with CKD. Materials and Methods: A cross-sectional study was conducted to estimate the total costs associated with the cost-of-illness, based on the prevalence of the disease at Kien Giang General Hospital. An electronic database provided information related to direct medical costs and biochemical parameters, whereas face-to-face interviews with CKD patients were conducted by questionnaire to collect demographic characteristics, direct non-medical costs and indirect costs. The population was divided into three groups based on the stages of CKD including the CKD 1–3 group, CKD 4–5 pre-dialysis group and haemodialysis group. Results: A total of 327 patients were enrolled in the study. Costs varied among three groups of CKD patients. The annual cost per patient in the CKD 1–3 group, CKD 4-5 pre-dialysis group and haemodialysis group were USD 2,826.3 (95%CI: 2,592.3–3,077.1), USD 3,320.3 (95%CI: 2,765.2–3,913.8) and USD 9,498.3 (95%CI: 9,152.5–9,881.4), respectively. Direct medical costs represented the greatest proportion of total costs. The annual cost per patient in the CKD 1–3 group was affected by many characteristics such as age, residence, BMI, education level, exercise and number of comorbidities. In contrast to the CKD 1–3 group, in the haemodialysis group most results were not significantly different in the yearly cost per patient according to demographic and clinical characteristics. Whereas, patients in the CKD 4–5 pre-dialysis group were impacted by factors such as age, residence, occupation and the number of comorbidities. Conclusion: The annual cost per patient in CKD 1–3, CKD 4–5 pre-dialysis and haemodialysis groups were substantial. Patients on haemodialysis incurred the highest cost, about three times compared with the other two groups. The differences in demographic and clinical characteristics affected the annual cost per patient, especially in the CKD 1–3 group.
Authors and Affiliations
Thai Quang Nguyen, Trung Quang Vo, Gia Hon Luu, Nghiem Quan Le
Keywords
Related Articles
- EP ID EP542059
- DOI 10.7860/JCDR/2018/36719.11716
- Views 72
- Downloads 0
Perception and Attitude of Medical Students towards Communication Skills Lab and Teaching Module
Introduction: The knowledge of proper communication skills with the patients plays a pivotal role in success of medical professionals. A practical approach would be to initiate its training at an early stage of education...
A Prospective Study to Analyse the Agreement between Empirical Antimicrobials used in Infective Endocarditis and Culture Sensitivity Reports
ABSTRACT Introduction: Infective Endocarditis (IE) is defined as a microbial infection of the heart valve or the mural endocardium. Annually the incidence of IE is between 2 and 6 per 100,000 individuals. The diagnostic...
Stereomicroscopic Dye Leakage Measurement of Six Different Root Canal Sealers
Introduction: Hermetic sealing of the root canal is the most desirable outcome of any root canal treatment, but almost always the filling of the root canal is defective, which is a multifactorial outcome. One such factor...
Atraumatic Restorative Treatment vs. Hall Technique for Occlusoproximal Lesions in Primary Dentition-An In vivo Study
Abstract Introduction: The economically deprived community often face significant barriers in accessing dental care and children too have unmet dental needs. The occlusoproximal surfaces of primary molars are more prone...
Uncovering Metabolic Syndrome among Chronic Obstructive Pulmonary Disease Patients in a Tertiary Care Hospital, India
Introduction: Chronic Obstructive Pulmonary Disease (COPD) is known to cause various systemic problems including Metabolic Syndrome (MetS). MetS is a group of cardiovascular risk factors. By assessing MetS, one can asses...